Рынок оборудования для размораживания клеток и генной терапии в Азиатско-Тихоокеанском регионе по модальности (настольное и портативное), образцу (клеточная терапия и генная терапия), типу ( ручная система размораживания и автоматическая система размораживания), применению (первичная и вторичная обработка), конечному пользователю ( банки крови и центры переливания крови, больницы и диагностические лаборатории, научно-исследовательские лаборатории и академические институты, биотехнологическая и фармацевтическая промышленность, банки пуповинной крови и стволовых клеток, генетические банки и другие), каналу сбыта (прямой тендер, сторонний дистрибьютор и другие), стране (Китай, Южная Корея, Япония, Индия, Австралия, Сингапур, Малайзия, Индонезия, Таиланд, Филиппины, остальные страны Азиатско-Тихоокеанского региона). Тенденции отрасли и прогноз до 2028 года.
Анализ рынка и аналитика: рынок оборудования для размораживания клеток и генной терапии в Азиатско-Тихоокеанском регионе
Ожидается, что рынок оборудования для размораживания клеток и генной терапии будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок растет со среднегодовым темпом роста 14,2% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 1 771,29 млн долларов США к 2028 году. Рост случаев генетических заболеваний, таких как сердечные заболевания, муковисцидоз и СПИД, требует передового оборудования для размораживания клеток и генной терапии, что является движущей силой роста рынка оборудования для размораживания клеток и генной терапии.
Оборудование для размораживания клеточной и генной терапии стало простым благодаря прогрессу в технологиях, поскольку ряд ключевых игроков рынка разрабатывают и запускают новые решения для расширения своего рынка. Более того, растущие расходы на здравоохранение в развитых, а также развивающихся странах подстегнули рост рынка оборудования для размораживания клеточной и генной терапии. Рынок оборудования для размораживания клеточной и генной терапии растет из-за увеличения числа хронических заболеваний и роста технологического прогресса.
Рост распространенности хронических заболеваний является движущей силой рынка оборудования для размораживания клеточной и генной терапии. Рост затрат, связанных с разработкой клеточной и генной терапии, снижает спрос на оборудование для размораживания клеточной и генной терапии, что сдерживает рост рынка оборудования для размораживания клеточной и генной терапии. Всплеск новых технологических достижений является возможностью для рынка оборудования для размораживания клеточной и генной терапии. Однако отсутствие доступности в странах с низким и средним уровнем дохода является проблемой для роста рынка оборудования для размораживания клеточной и генной терапии.
Отчет о рынке оборудования для размораживания клеток и генной терапии содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и сценарий рынка оборудования для размораживания клеток и генной терапии, свяжитесь с Data Bridge Market Research для получения аналитического обзора, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Объем рынка и размер оборудования для размораживания клеточной и генной терапии
Рынок оборудования для размораживания клеток и генной терапии сегментирован на основе модальности, образца, типа, применения, конечного пользователя, канала сбыта. Рост среди сегментов помогает вам анализировать нишевые карманы роста и стратегии подхода к рынку и определять ваши основные области применения и разницу в ваших целевых рынках.
- На основе выборки рынок оборудования для размораживания клеток и генной терапии сегментируется на клеточную терапию и генную терапию. Ожидается, что в 2021 году сегмент клеточной терапии будет доминировать на рынке оборудования для размораживания клеток и генной терапии из-за роста распространенности и заболеваемости раком.
- На основе типа рынок оборудования для размораживания клеточной и генной терапии сегментируется на ручные системы размораживания и автоматические системы размораживания. Ожидается, что в 2021 году сегмент автоматических систем размораживания будет доминировать на рынке оборудования для размораживания клеточной и генной терапии, поскольку он улучшает воспроизводимость и минимизирует человеческие ошибки.
- На основе применения рынок оборудования для размораживания клеточной и генной терапии сегментируется на апстрим-обработку и нисходящую обработку. Ожидается, что в 2021 году сегмент апстрим-обработки будет доминировать на рынке оборудования для размораживания клеточной и генной терапии из-за растущих технологических достижений в системах размораживания.
- На основе конечного пользователя рынок оборудования для размораживания клеточной и генной терапии сегментируется на банки крови и центры переливания крови, больницы и диагностические лаборатории, исследовательские лаборатории и академические институты, биотехнологическую и фармацевтическую промышленность, банки пуповинной крови и стволовых клеток, генные банки и др. Ожидается, что в 2021 году сегмент банков крови будет доминировать на рынке оборудования для размораживания клеточной и генной терапии из-за роста числа банков крови и передовых поставщиков медицинских услуг в странах с низким и средним уровнем дохода.
- На основе канала сбыта рынок оборудования для размораживания клеточной и генной терапии сегментируется на прямой тендер, стороннего дистрибьютора и другие. Ожидается, что в 2021 году сегмент прямого тендера будет доминировать на рынке оборудования для размораживания клеточной и генной терапии, поскольку большинство поставщиков медицинских услуг закупают оборудование для размораживания клеточной и генной терапии прямо на прямых тендерах.
Анализ рынка оборудования для размораживания клеток и генной терапии на уровне страны
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel.
The countries covered in the cell and gene therapy thawing equipment market report are Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and rest of Asia-Pacific.
China is leading the growth of the Asia-Pacific market and Benchtop segment is dominating in this country due to presence of highest number of cell and gene therapy thawing equipment providers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and Gene Therapy Thawing Equipment is boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market
The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Cell and Gene Therapy Thawing Equipment Market Share Analysis
Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Cell and gene therapy thawing equipment market.
The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Многие контракты и соглашения также инициируются компаниями по всему миру, которые также ускоряют развитие рынка оборудования для размораживания клеток и генной терапии.
Например,
- В ноябре 2020 года компания Eppendorg AG запустила SmartBlock для размораживания клеток в Индии. Smart Block Cell Thawing — это основа для последующей обработки. Он прост и удобен для ученых для дальнейшего использования в каждой лаборатории по работе с клетками.
Сотрудничество, запуск продукции, расширение бизнеса, награды и признание, совместные предприятия и другие стратегии участников рынка расширяют присутствие компании на рынке оборудования для размораживания клеток и генной терапии, что также обеспечивает рост прибыли организации.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES
5.1 UPSTREAM PROCESS
5.2 DOWNSTREAM PROCESS
6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT
7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS
7.1 CANADA
7.2 THE U.S.
7.3 EUROPE
7.4 GENE THERAPY LEGISLATION IN AUSTRIA
7.5 GENE THERAPY LEGISLATION IN BULGARIA
7.6 JAPAN
7.7 ITALY
7.8 MALAYSIA
8 REGIONAL SUMMARY
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA
9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES
9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD
9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS
9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS
9.2 RESTRAINTS
9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING
9.2.2 RISE OF UNWANTED MUTAGENS
9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS
9.2.4 STRICT REGULATORY FRAMEWORK
9.3 OPPORTUNITIES
9.3.1 INCREASING PREVALENCE OF CANCER
9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR
9.4 CHALLENGES
9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES
9.4.2 LACK OF ACCESSIBILITY
10 IMPACT OF COVID-19 ON ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT ON SUPPLY CHAIN
10.4 STRATEGIC DECISION FOR MANUFACTURERS
10.5 CONCLUSION
11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH TOP
11.3 PORTABLE
12 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE
12.1 OVERVIEW
12.2 CELL THERAPIES
12.2.1 CAR T CELLS
12.2.2 NK CELLS
12.2.3 MSCS
12.2.4 TILS
12.2.5 OTHERS
12.3 GENE THERAPIES
12.3.1 ADENOVIRUS
12.3.2 ADENO-ASSOCIATED VIRUSES
12.3.3 LENTIVIRUSES
12.3.4 ONCOLYTIC VIRUSES
12.3.5 OTHERS
13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
13.1 OVERVIEW
13.2 AUTOMATIC THAWING SYSTEM
13.3 MANUAL THAWING SYSTEM
14 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 UPSTREAM PROCESSING
14.2.1 AUTOMATIC THAWING SYSTEM
14.2.2 MANUAL THAWING SYSTEM
14.3 DOWNSTREAM PROCESSING
14.3.1 AUTOMATIC THAWING SYSTEM
14.3.2 MANUAL THAWING SYSTEM
15 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
15.3 BLOOD BANKS AND TRANSFUSION CENTERS
15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
15.6 CORD BLOOD AND STEM CELL BANKS
15.7 GENE BANKS
15.8 OTHERS
16 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 CHINA
17.1.2 INDIA
17.1.3 JAPAN
17.1.4 SOUTH KOREA
17.1.5 AUSTRALIA
17.1.6 SINGAPORE
17.1.7 THAILAND
17.1.8 MALAYSIA
17.1.9 INDONESIA
17.1.10 PHILIPPINES
17.1.11 REST OF ASIA PACIFIC
18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 MERCK KGAA
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 EPPENDORF AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 SARTORIUS AG
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 .RECENT DEVELOPMENTS
20.5 BARKEY
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENTS
20.6 BOEKEL SCIENTIFIC
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIOLINE INDIA
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENTS
20.8 COOK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 GENESIS BPS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 HELMER SCIENTIFIC INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 LABCOLD
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 PLEURISTEM THERAPEUTICS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 SARSTEDT AG & CO. KG
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
Список таблиц
TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 43 CHINA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 44 CHINA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 45 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 CHINA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 CHINA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 52 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 53 INDIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 54 INDIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 55 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 INDIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 INDIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 62 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 63 JAPAN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 64 JAPAN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 65 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 JAPAN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 JAPAN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 AUSTRALIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 AUSTRALIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 90 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 91 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 92 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 93 SINGAPORE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 94 SINGAPORE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 98 SINGAPORE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 102 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 103 THAILAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 104 THAILAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 105 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 THAILAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 THAILAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 120 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 125 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 INDONESIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 INDONESIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 129 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 130 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 134 PHILIPPINES GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 135 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 137 PHILIPPINES UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 PHILIPPINES DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 139 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 140 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
Список рисунков
FIGURE 1 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028
FIGURE 15 PESTEL ANALYSIS
FIGURE 16 PORTERS FIVE FORCES MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES
FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE
FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)
FIGURE 21 ASIA PACIFIC CANCER INCIDENCE (2018)
FIGURE 22 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020
FIGURE 23 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 24 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 25 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020
FIGURE 27 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)
FIGURE 28 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)
FIGURE 29 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020
FIGURE 31 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)
FIGURE 32 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)
FIGURE 33 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020
FIGURE 35 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 36 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020
FIGURE 39 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 40 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 44 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)
FIGURE 47 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)
FIGURE 48 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)
FIGURE 51 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)
FIGURE 52 COMPANY SHARE ANALYSIS
FIGURE 53 COMPANY SHARE ANALYSIS
FIGURE 54 COMPANY SHARE ANALYSIS
FIGURE 55 COMPANY SHARE ANALYSIS
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
